Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(75%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
2
50%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Completed(1)

Detailed Status

Recruiting2
Active, not recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (50.0%)
N/A2 (50.0%)

Trials by Status

active_not_recruiting125%
completed125%
recruiting250%

Recent Activity

3 active trials
Showing 4 of 4
recruitingnot_applicable

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

NCT07364175
recruitingphase_2

A Study of Blood Pressure Control During Cancer Treatment

NCT06023576
active_not_recruitingnot_applicable

The Home Blood Pressure (BP) Trial

NCT05159999
completedphase_2

Blood Pressure Lowering in Dialysis (BOLD) Trial

NCT03459807

Clinical Trials (4)

Showing 4 of 4 trials
NCT07364175Not Applicable

A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults

Recruiting
NCT06023576Phase 2

A Study of Blood Pressure Control During Cancer Treatment

Recruiting
NCT05159999Not Applicable

The Home Blood Pressure (BP) Trial

Active Not Recruiting
NCT03459807Phase 2

Blood Pressure Lowering in Dialysis (BOLD) Trial

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4